Fifteenth Report of the Iowa Library Commission Made to the Governor of Iowa for the Biennial Period July 1, 1928 to June 30, 1930 1928-1930

1928-1930 Iowa Library Commission Report made to the Governor of Iowa.

Sixteenth Report of the Iowa Library Commission Made to the Governor of Iowa for the Biennial Period July 1, 1930 to June 30, 1932

1930-1932 Iowa Library Commission Report made to the Governor of Iowa.

Seventeenth Report of the Iowa Library Commission Made to the Governor of Iowa for the Biennial Period July 1, 1932 to June 30, 1934

1932-1934 Iowa Library Commission Report made to the Governor of Iowa.

Eighteenth Report of the Iowa Library Commission Made to the Governor of Iowa for the Biannual Period July 1,1934 to June 30, 1936

1934-1936 Iowa Library Commission Report made to the Governor of Iowa.

Nineteenth Report of the Iowa Library Commission Made to the Governor of Iowa for the Biennial Period July 1,1936 to June 30, 1938

1936-1938 Iowa Library Commission Report made to the Governor of Iowa.

Differential pharmacologic properties of the two C75 enantiomers: (+)-C75 is a strong anorectic drug. (-)-C75 has antitumour activity

C75 is a synthetic compound described as having antitumoral properties. It produces hypophagia and weight loss in rodents, limiting its use in cancer therapy but identify- ing it as a potential anti-obesity drug. C75 is a fatty acid synthase (FAS) inhibitor and, through its coenzyme A (CoA) derivative, it acts as a carnitine palmitoyltransferase (CPT) 1 inhibitor. Racemic mixtures of C75 have been used in all the previous studies; however, the potential dif- ferent biological activities of C75 enantiomers have not been examined yet. To address this question we synthesized the two C75 enantiomers separately. Our results showed that ( )- C75 inhibits FAS activity in vitro and has a cytotoxic effect on tumor cell lines, without affecting food consumption. (+)-C75 inhibits CPT1 and its administration produces anorexia, suggesting that central inhibition of CPT1 is essential for the anorectic effect of C75. The differential activity of C75 enantiomers may lead to the development of potential new specific drugs for cancer and obesity.

Differential pharmacologic properties of the two C75 enantiomers: (+)-C75 is a strong anorectic drug. (-)-C75 has antitumour activity

C75 is a synthetic compound described as having antitumoral properties. It produces hypophagia and weight loss in rodents, limiting its use in cancer therapy but identify- ing it as a potential anti-obesity drug. C75 is a fatty acid synthase (FAS) inhibitor and, through its coenzyme A (CoA) derivative, it acts as a carnitine palmitoyltransferase (CPT) 1 inhibitor. Racemic mixtures of C75 have been used in all the previous studies; however, the potential dif- ferent biological activities of C75 enantiomers have not been examined yet. To address this question we synthesized the two C75 enantiomers separately. Our results showed that ( )- C75 inhibits FAS activity in vitro and has a cytotoxic effect on tumor cell lines, without affecting food consumption. (+)-C75 inhibits CPT1 and its administration produces anorexia, suggesting that central inhibition of CPT1 is essential for the anorectic effect of C75. The differential activity of C75 enantiomers may lead to the development of potential new specific drugs for cancer and obesity.

Iowa's Child Death Review Report to the Governor and General Assembly Annual Report 2008-2009

The goal of the Iowa Child Death Review Team is to identify those risks or factors in childhood (ages 17 and under) that result in fatal outcomes through a retrospective review of child death cases. A multidisciplinary team approach to reviewing child death cases is conducted. Recommendations made by the Team are based on data, which then are used to identify trends that require systemic solutions. In reviewing the number of child deaths in years 2008 and 2009, one can quickly discern that child death rates declined from 2008 to 2009, decreasing from 386 to 311 deaths. The incidence of child death was higher in those counties with greater populations within our state.

Iowa's Child Death Review Report to the Governor and General Assembly Annual Report 2010

The goal of the Iowa Child Death Review Team is to identify those risks or factors in childhood (ages 17 and under) that result in fatal outcomes through a retrospective review of child death cases. A multidisciplinary team approach to reviewing child death cases is conducted. Recommendations made by the Team are based on data, which then are used to identify trends that require systemic solutions.

Iowa's Child Death Review Report to the Governor and General Assembly Annual Report 2011

The goal of the Iowa Child Death Review Team is to identify those risks or factors in childhood (ages 17 and under) that result in fatal outcomes through a retrospective review of child death cases. A multidisciplinary team approach to reviewing child death cases is conducted. Recommendations made by the Team are based on data, which then are used to identify trends that require systemic solutions.

Iowa's Child Death Review Report to the Governor and General Assembly Annual Report 2012

The goal of the Iowa Child Death Review Team is to identify those risks or factors in childhood (ages 17 and under) that result in fatal outcomes through a retrospective review of child death cases. A multidisciplinary team approach to reviewing child death cases is conducted. Recommendations made by the Team are based on data, which then are used to identify trends that require systemic solutions.

Annual Report of the Hawk-i Board to The Governor, General Assembly, and Council on Human Services, December 2015

This report reflects one entire fiscal year of the Accountable Care Act changes. One of those changes was the method of how eligibility on January 2014, changing the income levels to 168 percent to 302 percent of the Federal Poverty Level.